{"schema_version":"secwatch.filing_event.v1","accession":"0001567264-24-000045","form_type":"8-K","ticker":"INTS","cik":"0001567264","company_name":"INTENSITY THERAPEUTICS, INC.","filed_at":"2024-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.820389+00:00","generated_at":"2026-05-30T11:05:22.901069+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Intensity Therapeutics grants stock options to CFO (427k shares) and controller (70k shares) at $3.44","bullets":["Options to CFO Joseph Talamo cover 427,379 shares; to Principal Accounting Officer John Wesolowski cover 70,028 shares.","Exercise price $3.44 per share, equal to fair market value on grant date (Oct 21, 2024).","Options vest in five equal annual installments beginning on the grant date.","Granted under the Company's 2021 Stock Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001567264-24-000045","json":"https://secwatch.observer/filing/0001567264-24-000045.json","markdown":"https://secwatch.observer/filing/0001567264-24-000045.md","text":"https://secwatch.observer/filing/0001567264-24-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/0001567264-24-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567264/000156726424000045/intensity-20241021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T11:05:22.901069+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}